Identification and validation of NEIL2 as a prognostic biomarker and potential therapeutic target in cervical cancer
The expression level of NEIL2 has a strong correlation with CC and affects its prognosis, which is expected to become a new prognostic biomarker in CC, providing an important reference for the diagnosis, mechanism research and treatment of cervical cancer.
Authors
- Lingjia Wei (ORCID: https://orcid.org/0000-0001-7492-4458)
- Tianmeng Tan
- Liming Bao (ORCID: https://orcid.org/0000-0001-9400-734X)
- Jinqiu Su
- He Wang
- Jiayuan Du
- Yan Li (ORCID: https://orcid.org/0000-0003-1163-0801)
Institutions
- Guangxi Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1007/s12672-025-02924-2
- Primary Topic
- Galectins and Cancer Biology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Guangxi Province